Zevia and Chemed Shares Plunge After Q4 Sales Miss Analyst Targets
Beverage maker Zevia and service conglomerate Chemed both reported fourth-quarter 2025 revenue that fell short of Wall Street expectations. The misses triggered significant sell-offs, with Chemed shares diving nearly 15% as investors recalibrate growth expectations for 2026.